In non-small cell lung cancer, GCN5 was proved to be recruited by E2F1 to E2F1-binding sites to regulate downstream target expression [16], but it turned out that down-regulation of GCN5 did not cause significant change of E2F1 expression in glioma cells. Here, E2F1 is linked to central nervous system cancer.